Group 1 - In October 17, 2023, Yingke Medical experienced a decline of 5.05%, with a stock price of 43.20 yuan per share, a trading volume of 1.434 billion yuan, a turnover rate of 6.69%, and a total market capitalization of 28.287 billion yuan [1] - Yingke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017. The company's main business includes three segments: personal protection, rehabilitation care, and other products [1] - The revenue composition of Yingke Medical is as follows: personal protection accounts for 91.47%, rehabilitation care for 4.75%, and other products for 3.77% [1] Group 2 - From the perspective of the top ten holdings of funds, one fund under Zheshang Securities Asset Management has a significant position in Yingke Medical. The Zheshang Huijin Quantitative Selected Stock A (011824) held 40,200 shares in the second quarter, representing 0.75% of the fund's net value, making it the second-largest holding [2] - The estimated floating loss for the fund on the current day is approximately 92,500 yuan. The Zheshang Huijin Quantitative Selected Stock A (011824) was established on July 1, 2021, with a latest scale of 63.808 million yuan. Year-to-date, it has achieved a return of 28.41%, ranking 1771 out of 4218 in its category; over the past year, it has returned 38.96%, ranking 1351 out of 3865; and since inception, it has returned 18.1% [2] Group 3 - The fund manager of Zheshang Huijin Quantitative Selected Stock A (011824) is Chen Gujun, who has been in the position for 5 years and 272 days. The total asset size of the fund is 204 million yuan, with the best fund return during his tenure being 40.06% and the worst being -7.57% [3]
英科医疗股价跌5.05%,浙商证券资管旗下1只基金重仓,持有4.02万股浮亏损失9.25万元